After Brain Injury, Astrocytes Ship Mitochondria to Struggling Neurons

Mitochondria, the organelles that power cellular metabolism, are essential for neuronal survival and synaptic function, and their dysfunction is a key consequence of the excitotoxicity that follows traumatic brain injury. A new open-access study in Acta Neuropathologica Communications reports that in mice, traumatic brain injury drives a measurable increase in astrocyte-to-neuron mitochondrial transfer, an adaptive response that unfolds alongside marked neuronal mitochondrial dysfunction.

To track the process, the team used astrocyte- and neuron-specific mitochondrial reporters, GFP or Dendra2, in mice, allowing cell-type-specific assessment of mitochondrial morphology, bioenergetics and transfer 24 hours after injury. The timing matters: rather than inferring events from tissue taken days or weeks later, the researchers captured the acute window in which damaged neurons and responding glia coexist.

What they saw was a stark asymmetry between the two cell types. Neurons exhibited marked mitochondrial dysfunction after injury, including altered morphology and reduced bioenergetic capacity measured across somatic, synaptic and non-neuronal fractions. Astrocytic mitochondria, by contrast, showed morphological changes but preserved bioenergetic function. In other words, the injury reshaped astrocyte mitochondria without crippling their energy-producing performance, while neuronal mitochondria bore the brunt of the excitotoxic insult.

Concomitantly, astrocyte-to-neuron mitochondrial transfer was significantly increased following injury compared with controls. Yet the rescue was incomplete in a telling way: transfer to synapses remained limited. The authors conclude that this process preserves neuronal bioenergetics in the soma and neurites but not at synapses, a spatial limitation they highlight alongside the therapeutic potential of the pathway.

To probe the mechanism, the researchers performed single-cell RNA sequencing of astrocytes, which revealed upregulation of genes involved in extracellular vesicle biogenesis and mitochondrial translation following injury compared to controls. That molecular signature suggested astrocytes were gearing up to package and ship material, including mitochondria, rather than simply responding passively to the injury environment.

In vitro co-culture studies then confirmed that astrocytes transfer mitochondria to neurons via extracellular vesicles containing mitochondria. The team went a step further, isolating EV-mito from astrocyte-conditioned media and testing them under controlled stress: the isolated vesicle-associated mitochondria improved neuronal mitochondrial function under N-methyl-D-aspartate-induced excitotoxic conditions, an in vitro model of the excitotoxic cascade central to brain injury pathology.

The findings carry clear therapeutic implications. If astrocyte-derived EV-mito can bolster neuronal mitochondrial function under excitotoxic stress in culture, purified or engineered versions of these vesicles could, in principle, be developed as bioenergetic supplements for injured tissue. Exogenous mitochondrial transplantation has already emerged as a strategy to restore cellular bioenergetics in other contexts, and this study grounds that idea in a specific, injury-triggered biological pathway within the central nervous system.

But the authors are careful about scope. They note that the in vivo relevance of intercellular mitochondrial transfer in the central nervous system remains incompletely understood, and their own data show the rescue is spatially uneven: synapses, the vulnerable contact points where neuronal communication actually happens, received little mitochondrial support.

It is also worth stressing what this study is and is not. It is a preclinical mouse study using genetic mitochondrial reporters, plus supporting in vitro co-culture experiments — not a human trial, and not a demonstration that EV-mito treatment improves outcomes after brain injury in patients. The published version is an early-release, peer-reviewed accepted article that is citable and carries a permanent DOI but remains subject to further edits before the final Version of Record.

Even so, the work reframes astrocytes in the aftermath of trauma. Long viewed chiefly as supporting cells that react to injury, they emerge here as active donors of functional mitochondria, mobilizing an adaptive transfer program within a day of insult. Decoding how that program is signaled, why synapses are shortchanged, and whether EV-mito can be harnessed safely will define the next phase of this research.

Subject of Research: Astrocyte-to-neuron mitochondrial transfer after traumatic brain injury and the therapeutic potential of astrocytic extracellular vesicle mitochondria

Article Title: TBI drives astrocytic mitochondrial transfer associated with neuronal mitochondrial dysfunction: therapeutic potential of astrocytic EV-mito

Article References: Velmurugan, G. V., Vekaria, H. J., Rabchevsky, A. G., Saito, K., Morganti, J. M., Patel, S. P., Hubbard, W. B., & Sullivan, P. G. (2026). TBI drives astrocytic mitochondrial transfer associated with neuronal mitochondrial dysfunction: therapeutic potential of astrocytic EV-mito. Acta Neuropathologica Communications. https://doi.org/10.1186/s40478-026-02458-w

Image Credits: AI Generated

DOI: 10.1186/s40478-026-02458-w

Keywords: traumatic brain injury, astrocytes, neurons, mitochondria, extracellular vesicles, mitochondrial transfer, bioenergetics, excitotoxicity, single-cell RNA sequencing, synapses, EV-mito, preclinical study